BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 7
• 8
• 9
• 10
• 11
• 13
• 14
• 15
• 16
• 17
• 18
• 21
• 22
• 23
• 24
• 25
• 28
• 29
• 30

• Press Releases

  Penumbra, Inc. to Present at the BofA Securities 2025 Health Care Conference

  April 29, 2025

   · 

  1 min read
• Press Releases

  Agenus to Provide Corporate Update and First Quarter 2025 Financial Report

  April 29, 2025

   · 

  2 min read
• Press Releases

  Ability Biotherapeutics Moves to Inspire Bio Innovations in Montreal, Pioneering the New Generation of Targeted Antibodies

  April 29, 2025

   · 

  4 min read
• Press Releases

  Harmony Biosciences to Report First Quarter 2025 Financial Results on May 6, 2025

  April 29, 2025

   · 

  1 min read
• Press Releases

  Tevard to Present Data Demonstrating tRNA-based Therapy Rescued Full-Length Dystrophin and Motor Function in Duchenne Muscular Dystrophy Model

  April 29, 2025

   · 

  2 min read
• Press Releases

  PlasCred Circular Innovations Inc. Announces First Closing of Private Placement and Amendment to Previously Announced Offering

  April 29, 2025

   · 

  3 min read
• Press Releases

  PreveCeutical Closes Initial Tranche of Up-Sized Non-Brokered Private Placement

  April 29, 2025

   · 

  5 min read
• Press Releases

  Lirum Therapeutics’ LX-101 New Positive Data Selected for Presentation at the 2025 American Association for Cancer Research (AACR) Annual Meeting

  April 29, 2025

   · 

  5 min read
• Press Releases

  Historic achievement: FDA approval of Abeona Therapeutics’ ZEVASKYN accelerates momentum and expands treatment options for the EB community.

  April 29, 2025

   · 

  7 min read
• Press Releases

  Innate Pharma Highlights Preclinical Anti-Tumor Efficacy Data of Its Antibody Drug Conjugate IPH4502 at the AACR 2025 Annual Meeting

  April 29, 2025

   · 

  6 min read